Published in J Infect Dis on October 01, 1979
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev (1997) 2.53
A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2. J Exp Med (1987) 1.78
Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci U S A (1994) 1.33
Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33
Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J Virol (1992) 1.17
Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity. J Clin Microbiol (1984) 1.08
Herpes simplex keratitis in renal transplant patients. Br J Ophthalmol (1991) 1.07
The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus. Clin Exp Immunol (1985) 0.90
Increased susceptibility to herpes simplex virus infections in children with acute measles. Infect Immun (1981) 0.88
Transmission of fatal herpes simplex infection through renal transplantation. Transplantation (1988) 0.88
Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity. Med Microbiol Immunol (2010) 0.83
Risk factors for viral reactivation following bone marrow transplantation. Ann Hematol (1992) 0.78
Intravenous acyclovir treatment for extensive herpetic keratitis in a liver transplant patient. Int Ophthalmol (1998) 0.78
Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. The Penciclovir Immunocompromised Study Group. Antimicrob Agents Chemother (1999) 0.77
Design, synthesis and antiviral activity studies of schizonepetin derivatives. Int J Mol Sci (2013) 0.75
Determination of patient herpes simplex virus immune status by latex agglutination. J Clin Microbiol (1988) 0.75
Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis. Int J Tryptophan Res (2013) 0.75
Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors. J Clin Microbiol (1981) 0.75
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med (1992) 5.11
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Racial equity in renal transplantation. The disparate impact of HLA-based allocation. JAMA (1993) 4.26
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet (1990) 4.12
A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med (1991) 3.78
Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med (1982) 3.66
The natural history of herpes simplex virus infection of mother and newborn. Pediatrics (1980) 3.65
Comparative study of diagnostic procedures for congenital cytomegalovirus infection. Pediatrics (1980) 3.53
Interference with cardiac pacemakers by cellular telephones. N Engl J Med (1997) 3.45
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA (1986) 3.37
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics (1980) 3.21
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98
Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr (1997) 2.93
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70
Infection of the newborn with herpesvirus hominis. Adv Pediatr (1970) 2.61
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med (1978) 2.52
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48
Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J (1992) 2.40
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Studies on antibody in congenital rubella infections. I. Physicochemical and immunologic investigations of rubella neutralizing antibody. Am J Dis Child (1965) 2.37
Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol (2000) 2.36
Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics (1980) 2.35
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation (1991) 2.32
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med (1973) 2.21
Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency. N Engl J Med (1974) 2.16
Gamma-M-fluorescent treponemal antibody in the diagnosis of congenital syphilis. N Engl J Med (1969) 2.10
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med (1976) 2.09
A correlative immunologic, microbiologic and clinical approach to the diagnosis of acute and chronic infections in newborn infants. N Engl J Med (1967) 2.09
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Renal transplantation in children with posterior urethral valves. J Urol (1991) 2.06
Congenital and perinatal cytomegalovirus infections. Rev Infect Dis (1990) 2.04
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A (2000) 1.99
Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis (1975) 1.97
RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97
Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics (1999) 1.96
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr (1992) 1.94
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis (1991) 1.94
Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta (1977) 1.84
Herpes simplex encephalitis. Clinical Assessment. JAMA (1982) 1.83
Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr (1999) 1.78
Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull N Y Acad Med (1974) 1.69
Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis (1983) 1.67
Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics (1977) 1.66
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66
Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med (1988) 1.60
Diagnostic specificity of Widal's reaction for typhoid fever. JAMA (1970) 1.58
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther (1998) 1.57
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics (1981) 1.57
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis (1973) 1.54
Microchimerism and rejection in clinical transplantation. Lancet (1997) 1.53
Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther (1979) 1.52
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child (1979) 1.51
Subclinical central nervous system disease of neonates: a prospective study of infants born with increased levels of IgM. J Pediatr (1969) 1.50
Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis (1996) 1.50
Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation. J Infect Dis (1975) 1.49
Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med (1986) 1.49
Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med (1985) 1.47
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis (1983) 1.47
Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol (1982) 1.46
Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med (1980) 1.46